SKADDEN, ARPS, SLATE, MEAGHER & FLOM
DIRECT DIAL +852 3740 4863 DIRECT FAX +852 3910 4863 EMAIL ADDRESS JULIE.GAO@SKADDEN.COM
PARTNERS CHRISTOPHER W. BETTS GEOFFREY CHAN * ANDREW L. FOSTER * CHI T. STEVE KWOK * EDWARD H.P. LAM ◆* HAIPING LI * RORY MCALPINE ◆ JONATHAN B. STONE * PALOMA P. WANG ◆ (ALSO ADMITTEDIN ENGLAND & WALES) * (ALSO ADMITTEDIN NEW YORK)
REGISTERED FOREIGN LAWYER Z. JULIE GAO (CALIFORNIA) | 世達國際律師事務所
42/F, EDINBURGH TOWER, THE LANDMARK 15 QUEEN’S ROAD CENTRAL, HONG KONG
TEL: (852) 3740-4700 FAX: (852) 3740-4727 www.skadden.com
December 20, 2019 | AFFILIATE OFFICES —————— BOSTON CHICAGO HOUSTON LOS ANGELES NEW YORK PALO ALTO WASHINGTON, D.C. WILMINGTON —————— BEIJING BRUSSELS FRANKFURT LONDON MOSCOW MUNICH PARIS SÃO PAULO SEOUL SHANGHAI SINGAPORE TOKYO TORONTO |
VIA EDGAR
Ms. Barbara Jacobs
Mr. Michael C. Foland
Mr. Stephen Krikorian
Ms. Morgan Youngwood
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Re: | Molecular Data Inc. (CIK No. 0001758736) |
Registration Statement on Form F-1 (File No. 333-235398)
Dear Ms. Jacobs, Mr. Foland, Mr. Krikorian, and Ms. Youngwood:
On behalf of our client, Molecular Data Inc., a foreign private issuer organized under the laws of the Cayman Islands (the “Company”), we are filing herewith Amendment No. 1 to the Company’s registration statement on Form F-1 (the “Registration Statement”) containing a preliminary prospectus with a price range and certain exhibits via EDGAR to the Securities and Exchange Commission (the “Commission”).
To facilitate your review, we are separately delivering to you today four courtesy copies of the Registration Statement, marked to show changes to the registration statement filed with the Commission on December 6, 2019, as well as two copies of the filed exhibits.
U.S. Securities and Exchange Commission
December 20, 2019
Page 2
The Company respectfully advises the Staff that the Company plans to commence the road show for the proposed offering on or about December 23, 2019. In addition, the Company plans to request that the Staff declare the effectiveness of the Registration Statement on or about December 27, 2019, and will file joint acceleration requests in time before the requested effective time. The Company would greatly appreciate the Staff’s continuing assistance and support to the Company in meeting the proposed timetable for the offering.
* * *
U.S. Securities and Exchange Commission
December 20, 2019
Page 3
If you have any questions regarding the Registration Statement, please contact the undersigned by phone at +852 3740-4863 or via e-mail at julie.gao@skadden.com.
Very truly yours, |
/s/ Z. Julie Gao |
Z. Julie Gao |
Enclosures
cc: | Dongliang Chang, Founder and Chairman of the Board of Directors, Molecular Data Inc. |
Zheng Wang, Chief Executive Officer, Molecular Data Inc.
Zhaohong Li, Chief Financial Officer, Molecular Data Inc.
Haiping Li, Esq., Partner, Skadden, Arps, Slate, Meagher & Flom LLP
Henry Song, Partner, Ernst & Young Hua Ming LLP
Li He, Esq., Partner, Davis Polk & Wardwell LLP
James C. Lin, Esq., Partner, Davis Polk & Wardwell LLP